Recruiting NCT03684109

Non-invasive Glioma Characterization Through Molecular Imaging

Trial Parameters

Condition Glioma

Sponsor University of Miami

Study Type INTERVENTIONAL

Phase N/A

Enrollment 30

Sex ALL

Min Age 18 Years

Max Age N/A

Start Date 2019-01-25

Completion 2026-01-31

All Conditions

Glioma Brain Tumor Primary Brain Tumor Malignant Glioma Malignant Primary Brain Tumor

Interventions

3T MRI Scanner

Brief Summary

MRI-based sequences can provide non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor cellularity in human gliomas and help guide the development of novel glioma therapies.

Eligibility Criteria

Inclusion Criteria: * Adults (≥18 year old) * Subjects with suspected or confirmed gliomas and who will have a medically indicated biopsy or resection of his/her brain lesion. Exclusion Criteria: * Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Patients unable to have MRI done

Related Trials

NCT05770544

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients

View Trial →

NCT02800486

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treat

View Trial →

NCT04699773

LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)

View Trial →

VIEW ON CLINICALTRIALS.GOV ↗ MORE GLIOMA TRIALS